Peter Lewandrowski

This inventor holds 33 USPTO granted patents and 7 published patent applications, plus 8 CIPO patents and 21 EPO patents. Top assignee: Immatics Biotechnologies Gmbh. Active years: 2011-2024.

USPTO Granted Patents = 33 (Patent Applications = 7)

% Patents Active = 97.0

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 21 (Patent Applications = 22)

Average Co-Inventor Count = 4.6

ph-index = 17

Forward Citations = 724(Granted Patents)

Location History:

Tuenbingen-Hirschau, DE (2015)
Tubingen-Unterjesingen, DE (2014 - 2016)
Tuebingen-Unterjesingen, DE (2016)
Tuebingen-Hirschau, DE (2011 - 2024)
Tuebingen, DE (2022 - 2024)

Company Filing History:

32 out of 728

Immatics Biotechnologies Gmbh

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

Areas of Expertise:

Immunotherapy

Tumor-Associated Peptides

Gastric Cancer

MHC-Class II Peptides

HLA-Binding Peptides

Anti-Cancer Vaccines

Gastrointestinal Cancer

Peptide Formulations

Cancer Treatment

Survivin-Derived Peptides

Prostate-Associated Antigens

Vaccine Development

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064465 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2024-08-20),

2. 11975042 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2024-05-07),

3. 11969455 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2024-04-30),

4. 11957730 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2024-04-16),

5. 11957729 - Powerful MHC-class II peptides derived from survivin (2024-04-16),

6. 11883462 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2024-01-30),

7. 11850274 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2023-12-26),

8. 11839643 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2023-12-12),

9. 11648292 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2023-05-16),

10. 11298404 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2022-04-12),

11. 11273200 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2022-03-15),

12. 11077171 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2021-08-03),

13. 10933118 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2021-03-02),

14. 10905741 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2021-02-02),

15. 10898546 - Immunotherapy against several tumors including gastrointestinal and gastric cancer (2021-01-26),

Title: The Innovative Journey of Peter Lewandrowski

Introduction: Peter Lewandrowski, a talented inventor hailing from Tuebingen-Hirschau, Germany, has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Peter Lewandrowski's latest patents include a cutting-edge virtual reality headset designed to revolutionize the gaming industry and a solar-powered device for sustainable energy generation.

Career Highlights: With a career spanning over two decades, Peter Lewandrowski has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its creativity and practicality.

Collaborations: Throughout his career, Peter Lewandrowski has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Peter Lewandrowski's passion for innovation and commitment to pushing the boundaries of technology have solidified his reputation as a pioneering inventor in the industry. His relentless pursuit of excellence continues to inspire the next generation of inventors worldwide.